Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0302000X0BBAAAA |
| Virtual Medicinal Product | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device |
| Name | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device |
| Abbreviated name | Atectura Breezhaler 125microg/62.5microg inhalation pdr caps |
| Date of name applicability | 24 Nov 2020 |
| Previous name | Atectura Breezhaler 125micrograms/62.5 micrograms inhalation powder capsules with device |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Not available |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
dm+d data retrieved from TRUD: release NHSBSA_6.4.0_20250630000001, imported on 30th June 2025 at 05:10:36.